The largest database of trusted experimental protocols

3 protocols using ly2886721

1

Investigating Alzheimer's Pathogenesis with LY-2886721

Check if the same lab product or an alternative is used in the 5 most similar protocols
LY‐2886721 (Selleck Chemicals) was prepared fresh from frozen stocks before administration and was dissolved in the differentiation medium, at 5 µmol/L as working concentration, as described previously.27, 28 Then, we treated the 6‐week‐differentiated iPSC‐derived neurons with LY‐2886721 for 5 days and investigated the effects on Aβ and p‐Tau levels.
+ Open protocol
+ Expand
2

Amyloid-β Inhibitor Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
LY2886721, LY2811376, AZD3293, AZD3839, MK-8931, Pepstatin A, TAPI-1, Batimastat and DAPT were from Selleckchem; E2609 was from Sun-Shine Chemical; PF-06751979 was from MedChemExpree; β-secretase inhibitor IV was from Millipore; GI 254023X was from TOCRIS; Roburic acid was from Aobious; synthetic β-amyloid peptides are all from Anasepc; and recombinant human BACEl and BACE2 protein was from R&D system.
+ Open protocol
+ Expand
3

Inhibition of ADAM Proteases in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitors LY2886721, Lanabecestat, and Marimastat were from Selleck Chemicals and TMI-1 was from Tocris Sciences. Anti-ADAM17 and anti-ADAM9 were from Cell Signaling Technology (Cat:3976S and 4151S, 1:000 dilution), anti-BACE2 antibody was from Santa Cruz Biotechnology (sc-271212, 1:1000 dilution), and anti-MSLN antibody (mouse monoclonal MN, 1 ug/ml) was from our lab. siRNAs against human ADAM17: s13719 (siADAM17_1) and si13720 (siADAM17_2) and one siRNA targeting ADAM10: s1004 were from Thermo Fisher Scientific. All other On-Target Plus siRNA and negative control siRNA luciferase GL2 were from Dharmacon.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!